S. L. Beal and L. B. Sheiner, Estimating population kinetics, CRC Critical Reviews in Biomedical Engineering, vol.8, pp.195-222, 1982.

L. M. Berezhkovskiy, Volume of Distribution at Steady State for a Linear Pharmacokinetic System with Peripheral Elimination, Journal of Pharmaceutical Sciences, vol.93, issue.6, pp.1628-1640, 2004.
DOI : 10.1002/jps.20073

P. Bernillon and F. Y. Bois, Statistical Issues in Toxicokinetic Modeling: A Bayesian Perspective, Environmental Health Perspectives, vol.108, issue.s5, pp.883-893, 2000.
DOI : 10.1289/ehp.00108s5883

URL : https://hal.archives-ouvertes.fr/ineris-00961852

K. T. Bogen and R. C. Spear, Integrating Uncertainty and Interindividual Variability in Environmental Risk Assessment, Risk Analysis, vol.6, issue.4, pp.427-436, 1987.
DOI : 10.1111/j.1539-6924.1987.tb00480.x

F. Y. Bois, Analysis of PBPK Models for Risk Characterization, Annals of the New York Academy of Sciences, vol.43, issue.9, pp.317-337, 1999.
DOI : 10.1016/0041-008X(90)90037-U

URL : https://hal.archives-ouvertes.fr/ineris-00962759

F. Y. Bois, Statistical Analysis of Clewell et al. PBPK Model of Trichloroethylene Kinetics, Environmental Health Perspectives, vol.108, issue.s2, pp.307-316, 2000.
DOI : 10.1289/ehp.00108s2307

URL : https://hal.archives-ouvertes.fr/ineris-00961854

F. Y. Bois, Applications of population approaches in toxicology, Toxicology Letters, vol.120, issue.1-3, pp.385-394, 2001.
DOI : 10.1016/S0378-4274(01)00270-3

URL : https://hal.archives-ouvertes.fr/ineris-00972203

F. Y. Bois, Physiologically Based Modelling and Prediction of Drug Interactions, Basic & Clinical Pharmacology & Toxicology, vol.31, issue.9, pp.154-161, 2010.
DOI : 10.1111/j.1742-7843.2009.00488.x

F. Y. Bois and C. Diack, Uncertainty Analysis: The Bayesian Approach, Quantitative Methods for Cancer and Human health Risk Assessment, 2005.
DOI : 10.1002/0470857706.ch15

URL : https://hal.archives-ouvertes.fr/ineris-00969372

F. Y. Bois, A. Gelman, J. Jiang, D. Maszle, L. Zeise et al., Population toxicokinetics of tetrachloroethylene, Archives of Toxicology, vol.70, issue.6, pp.347-355, 1996.
DOI : 10.1007/s002040050284

URL : https://hal.archives-ouvertes.fr/ineris-00969532

F. Y. Bois, E. T. Jackson, K. Pekari, and M. T. Smith, Population toxicokinetics of benzene, Environmental Health Perspectives, vol.104, issue.Suppl 6, pp.1405-1411, 1996.
DOI : 10.1289/ehp.961041405

H. J. Clewell, . Iii, P. R. Gentry, J. M. Gearhart, T. R. Covington et al., Development of a Physiologically Based Pharmacokinetic Model of Isopropanol and Its Metabolite Acetone, Toxicological Sciences, vol.63, issue.2, pp.160-172, 2001.
DOI : 10.1093/toxsci/63.2.160

H. J. Clewell and B. M. Jarnot, Incorporation of Pharmacokinetics in Noncancer Risk Assessment: Example with Chloropentafluorobenzene, Risk Analysis, vol.7, issue.105, pp.265-276, 1994.
DOI : 10.1016/0378-4274(93)90123-F

T. R. Covington, P. R. Gentry, C. B. Van-landingham, M. E. Andersen, J. E. Kester et al., The use of Markov chain Monte Carlo uncertainty analysis to support a Public Health Goal for perchloroethylene, Regulatory Toxicology and Pharmacology, vol.47, issue.1, pp.1-18, 2007.
DOI : 10.1016/j.yrtph.2006.06.008

R. M. David, H. J. Clewell, P. R. Gentry, T. R. Covington, D. A. Morgott et al., Revised assessment of cancer risk to dichloromethane II. Application of probabilistic methods to cancer risk determinations, Regulatory Toxicology and Pharmacology, vol.45, issue.1, pp.55-65, 2006.
DOI : 10.1016/j.yrtph.2005.12.003

M. Davidian and A. R. Gallant, Smooth nonparametric maximum likelihood estimation for population pharmacokinetics, with application to quinidine, Journal of Pharmacokinetics and Biopharmaceutics, vol.11, issue.60, pp.529-556, 1992.
DOI : 10.1007/BF01061470

B. Davies and T. Morris, Physiological parameters in laboratory animals and humans, Pharmaceutical Research, vol.10, issue.7, pp.1093-1095, 1993.
DOI : 10.1023/A:1018943613122

S. S. Davis, J. G. Hardy, and J. W. Fara, Transit of pharmaceutical dosage forms through the small intestine., Gut, vol.27, issue.8, pp.886-892, 1986.
DOI : 10.1136/gut.27.8.886

G. L. De-la-grandmaison, I. Clairand, and M. Durigon, Organ weight in 684 adult autopsies: new tables for a Caucasoid population, Forensic Science International, vol.119, issue.2, pp.149-154, 2001.
DOI : 10.1016/S0379-0738(00)00401-1

M. J. Dresser, M. K. Leabman, and K. M. Giacomini, Transporters involved in the elimination of drugs in the kidney: Organic anion transporters and organic cation transporters, Journal of Pharmaceutical Sciences, vol.90, issue.4, pp.397-421, 2001.
DOI : 10.1002/1520-6017(200104)90:4<397::AID-JPS1000>3.0.CO;2-D

G. Ghibellini, L. S. Vasist, E. M. Leslie, W. D. Heizer, R. J. Kowalsky et al., In Vitro???In Vivo Correlation of Hepatobiliary Drug Clearance in Humans, Clinical Pharmacology & Therapeutics, vol.33, issue.3, pp.406-413, 2007.
DOI : 10.1007/BF01059688

M. K. Grandison and F. D. Boudinot, Age-Related Changes in Protein Binding of Drugs, Clinical Pharmacokinetics, vol.30, issue.5, pp.271-290, 2000.
DOI : 10.2165/00003088-200038030-00005

A. Grover and L. Benet, Effects of Drug Transporters on Volume of Distribution, The AAPS Journal, vol.11, issue.2, pp.250-261, 2009.
DOI : 10.1208/s12248-009-9102-7

C. E. Hack, W. A. Chiu, Q. J. Zhao, and H. J. Clewell, Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites, Regulatory Toxicology and Pharmacology, vol.46, issue.1, pp.63-83, 2006.
DOI : 10.1016/j.yrtph.2006.05.012

J. Hadgraft and R. H. Guty, Feasibility assessment in topical and transdermal delivery: mathematical models and in vitro studies, Transdermal Drug Delivery, Informa Health Care, pp.1-25, 2002.

C. Hilgendorf, G. Ahlin, A. Seithel, P. Artursson, A. L. Ungell et al., Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines, Drug Metabolism and Disposition, vol.35, issue.8, pp.1333-1340, 2007.
DOI : 10.1124/dmd.107.014902

R. H. Ho and R. B. Kim, Transporters and drug therapy: Implications for drug disposition and disease, Clinical Pharmacology & Therapeutics, vol.78, issue.3, pp.260-277, 2005.
DOI : 10.1016/j.clpt.2005.05.011

J. B. Houston, Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance, Biochemical Pharmacology, vol.47, issue.9, pp.1469-1479, 1994.
DOI : 10.1016/0006-2952(94)90520-7

E. M. Howgate, R. Yeo, K. Proctor, N. J. Tucker, G. T. Rostami-hodjegan et al., data. I: Impact of inter-individual variability, Xenobiotica, vol.29, issue.1, pp.473-497, 2006.
DOI : 10.1097/00008571-200003000-00001

A. Nong, Y. M. Tan, M. E. Krolski, J. S. Wang, C. Lunchick et al., Bayesian Calibration of a Physiologically Based Pharmacokinetic/Pharmacodynamic Model of Carbaryl Cholinesterase Inhibition, Journal of Toxicology and Environmental Health, Part A, vol.11, issue.20, pp.1363-1381, 2008.
DOI : 10.1016/0024-3205(82)90426-X

R. S. Obach, Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes, Drug Metab Dispos, vol.27, pp.1350-1359, 1999.

M. F. Paine, H. L. Hart, S. S. Ludington, R. L. Haining, A. E. Rettie et al., THE HUMAN INTESTINAL CYTOCHROME P450 "PIE", Drug Metabolism and Disposition, vol.34, issue.5, pp.880-886, 2006.
DOI : 10.1124/dmd.105.008672

M. F. Paine, M. Khalighi, J. M. Fisher, D. D. Shen, K. L. Kunze et al., Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism, J Pharmacol Exp Ther, vol.283, pp.1552-1562, 1997.

K. S. Pang, R. O. Potts, and R. H. Guy, Modeling of intestinal drug absorption: roles of transporters and metabolic Predicting Skin Permeability, Pharmaceutical Research, vol.9, pp.663-669, 1992.

P. Poulin, K. Schoenlein, and F. P. Theil, Prediction of adipose tissue: Plasma partition coefficients for structurally unrelated drugs, Journal of Pharmaceutical Sciences, vol.90, issue.4, pp.436-447, 2001.
DOI : 10.1002/1520-6017(200104)90:4<436::AID-JPS1002>3.0.CO;2-P

P. Poulin and F. P. Theil, A Priori Prediction of Tissue:Plasma Partition Coefficients of Drugs to Facilitate the Use of Physiologically???Based Pharmacokinetic Models in Drug Discovery, Journal of Pharmaceutical Sciences, vol.89, issue.1, pp.16-35, 2000.
DOI : 10.1002/(SICI)1520-6017(200001)89:1<16::AID-JPS3>3.0.CO;2-E

P. Poulin and F. P. Theil, Prediction of Pharmacokinetics Prior to In Vivo Studies. 1. Mechanism???Based Prediction of Volume of Distribution, Journal of Pharmaceutical Sciences, vol.91, issue.1, pp.129-156, 2002.
DOI : 10.1002/jps.10005

P. Poulin and F. P. Theil, Prediction of Pharmacokinetics Prior to In Vivo Studies. II. Generic Physiologically Based Pharmacokinetic Models of Drug Disposition, Journal of Pharmaceutical Sciences, vol.91, issue.5, pp.1358-1370, 2002.
DOI : 10.1002/jps.10128

P. S. Price, R. B. Conolly, C. F. Chaisson, E. A. Gross, J. S. Young et al., Modeling Interindividual Variation in Physiological Factors Used in PBPK Models of Humans, Critical Reviews in Toxicology, vol.10, issue.3, pp.469-503, 2003.
DOI : 10.1080/07315724.1998.10720457

N. J. Proctor, G. T. Tucker, and A. Rostami-hodjegan, Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors, Xenobiotica, vol.40, issue.2, pp.151-178, 2004.
DOI : 10.1021/bi000869u

J. Qiu, Y. C. Chien, J. V. Bruckner, and J. W. Fisher, Bayesian Analysis of a Physiologically Based Pharmacokinetic Model for Perchloroethylene in Humans, Journal of Toxicology and Environmental Health, Part A, vol.117, issue.6, pp.74-91, 2010.
DOI : 10.1023/A:1011555016423

A. Racine-poon and A. F. Smith, Population Models, Statistical Methodology in the Pharmaceutical Sciences, pp.139-162, 1990.
DOI : 10.1201/b16950-6

A. Rane, G. R. Wilkinson, and D. G. Shand, Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance, J Pharmacol Exp Ther, vol.200, pp.420-424, 1977.

M. Rowland and T. N. Tozer, Clinical pharmacokinetics: concepts and applications, 1995.

A. Sato, The effect of environmental factors on the pharmacokinetic behaviour of organic solvent vapours, Ann Occup Hyg, vol.35, pp.525-541, 1991.

Y. Sawada, M. Hanano, Y. Sugiyama, H. Harashima, and T. Iga, Prediction of the volumes of distribution of basic drugs in humans based on data from animals, Journal of Pharmacokinetics and Biopharmaceutics, vol.110, issue.6, pp.587-596, 1984.
DOI : 10.1007/BF01059554

U. F. Schaefer, S. Hansen, M. Schneider, J. L. Contreras, and C. Lehr, Models for skin absorption and skin toxicity testing. Drug Absorption Studies, pp.3-33, 2008.

L. B. Sheiner, The Population Approach to Pharmacokinetic Data Analysis: Rationale and Standard Data Analysis Methods, Drug Metabolism Reviews, vol.27, issue.1-2, pp.153-171, 1984.
DOI : 10.1214/aoms/1177706645

A. F. Smith and J. Wakefield, The hierarchical Bayesian approach to population pharmacokinetic modelling, International Journal of Bio-Medical Computing, vol.36, issue.1-2, pp.35-42, 1994.
DOI : 10.1016/0020-7101(94)90093-0

R. C. Spear, F. Y. Bois, T. Woodruff, D. Auslander, J. Parker et al., Modeling Benzene Pharmacokinetics Across Three Sets of Animal Data: Parametric Sensitivity and Risk Implications, Risk Analysis, vol.74, issue.4, pp.641-654, 1991.
DOI : 10.1016/0041-008X(84)90064-4

S. E. Tett, C. M. Kirkpatrick, A. S. Gross, and A. J. Mclachlan, Principles and Clinical Application of Assessing Alterations in Renal Elimination Pathways, Clinical Pharmacokinetics, vol.52, issue.1, pp.1193-1211, 2003.
DOI : 10.2165/00003088-200342140-00002

P. Thirup, Haematocrit, Sports Medicine, vol.85, issue.6, pp.231-243, 2003.
DOI : 10.2165/00007256-200333030-00005

A. Tsuji and I. Tamai, Carrier-mediated intestinal transport of drugs, Pharmaceutical Research, vol.13, issue.7, pp.963-977, 1996.
DOI : 10.1023/A:1016086003070

G. T. Tucker, Measurement of the renal clearance of drugs., British Journal of Clinical Pharmacology, vol.68, issue.Supplement, pp.761-770, 1981.
DOI : 10.1111/j.1365-2125.1981.tb01304.x

P. Vicini, C. H. Pierce, R. L. Dills, M. S. Morgan, and D. A. Kalman, Individual Prior Information in a Physiological Model of 2H8-Toluene Kinetics: An Empirical Bayes Estimation Strategy, Risk Analysis, vol.21, issue.6, pp.1127-1134, 1999.
DOI : 10.1021/js9603562

O. Von-richter, O. Burk, M. F. Fromm, K. P. Thon, M. Eichelbaum et al., Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens, Clinical Pharmacology & Therapeutics, vol.75, issue.3, pp.172-183, 2004.
DOI : 10.1016/j.clpt.2003.10.008

J. Wakefield and J. Bennett, The Bayesian Modeling of Covariates for Population Pharmacokinetic Models, Journal of the American Statistical Association, vol.43, issue.435, pp.917-927, 1996.
DOI : 10.2307/2986121

Z. J. Wang, O. Q. Yin, B. Tomlinson, and M. S. Chow, OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine, Pharmacogenetics and Genomics, vol.18, issue.7, pp.637-645, 2008.
DOI : 10.1097/FPC.0b013e328302cd41

G. R. Wilkinson, Clearance approaches in pharmacology, Pharmacol Rev, vol.39, pp.1-47, 1987.

L. R. Williams and R. W. Leggett, Reference values for resting blood flow to organs of man, Clinical Physics and Physiological Measurement, vol.10, issue.3, pp.187-217, 1989.
DOI : 10.1088/0143-0815/10/3/001

S. Willmann, A. N. Edginton, M. Kleine-besten, E. Jantratid, K. Thelen et al., Whole-body physiologically based pharmacokinetic population modelling of oral drug administration: inter-individual variability of cimetidine absorption, Journal of Pharmacy and Pharmacology, vol.53, issue.7, pp.891-899, 2009.
DOI : 10.1211/jpp.61.07.0008

S. Willmann, K. Höhn, A. Edginton, M. Sevestre, J. Solodenko et al., Development of a Physiology-Based Whole-Body Population Model for Assessing the Influence of Individual Variability on the Pharmacokinetics of Drugs, Journal of Pharmacokinetics and Pharmacodynamics, vol.38, issue.2, pp.401-431, 2007.
DOI : 10.1007/s10928-007-9053-5

T. Woodruff and F. Y. Bois, Optimization issues in physiological toxicokinetic modeling: a case study with benzene, Toxicology Letters, vol.69, issue.2, pp.181-196, 1993.
DOI : 10.1016/0378-4274(93)90103-5

T. Woodruff, F. Y. Bois, D. Auslander, and R. Spear, Structure and Parameterization of Pharmacokinetic Models: Their Impact on Model Predictions, Risk Analysis, vol.8, issue.2, pp.189-201, 1992.
DOI : 10.1016/0378-4274(91)90157-2

J. Yang, M. Jamei, K. R. Yeo, G. T. Tucker, and A. Rostami-hodjegan, Prediction of Intestinal First-Pass Drug Metabolism, Current Drug Metabolism, vol.8, issue.7, pp.676-684, 2007.
DOI : 10.2174/138920007782109733

J. Yang, A. Rostami-hodjegan, and G. T. Tucker, Prediction of ketoconazole interaction with midazolam, alprazolam and triazolam: incorporating population variability, Blackwell Science Ltd, pp.472-473, 2001.

J. Yu and G. Rosania, Cell-Based Multiscale Computational Modeling of Small Molecule Absorption and Retention in the Lungs, Pharmaceutical Research, vol.32, issue.3, pp.457-467, 2010.
DOI : 10.1007/s11095-009-0034-9

L. X. Yu and G. L. Amidon, A compartmental absorption and transit model for estimating oral drug absorption, International Journal of Pharmaceutics, vol.186, issue.2, pp.119-125, 1999.
DOI : 10.1016/S0378-5173(99)00147-7

L. X. Yu, J. R. Crison, and G. L. Amidon, Compartmental transit and dispersion model analysis of small intestinal transit flow in humans, International Journal of Pharmaceutics, vol.140, issue.1, pp.111-118, 1996.
DOI : 10.1016/0378-5173(96)04592-9